Boehringer Ingelheim: all 2,305 studies
Page 11 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in BelgiumCompletedNCT00886288Results posted
- 4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM)CompletedNCT00885118Phase 2Results posted
- Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label ExtensionCompletedNCT00881530Phase 2Results posted
- Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced PatientsCompletedNCT00879411Results posted
- Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00877929Phase 3Results posted
- Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected PatientsCompletedNCT00876733Results posted
- BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase ICompletedNCT00876460Phase 1Results posted
- Afatinib (BIBW 2992) QTcF Trial in Patients With Relapsed or Refractory Solid TumoursCompletedNCT00875433Phase 2Results posted
- Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe HypertensionCompletedNCT00860262Phase 3Results posted
- Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement SurgeryCompletedNCT00847301Results posted
- Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement SurgeryCompletedNCT00846807Results posted
- BI 1744 CL With Respimat Once Daily Versus Twice Daily in COPDCompletedNCT00846768Phase 2Results posted
- Safety and Tolerability of Dabigatran Etexilate in AdolescentsCompletedNCT00844415Phase 2Results posted
- Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive DisorderCompletedNCT00844194Phase 4Results posted
- 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or TrastuzumabCompletedNCT00826267Phase 2Results posted
- Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLCCompletedNCT00824408Phase 2Results posted
- Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPDCompletedNCT00824382Phase 2Results posted
- Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea DrugCompletedNCT00819091Phase 3Results posted
- Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected PatientsCompletedNCT00819052Phase 3Results posted
- Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary InterventionCompletedNCT00818753Phase 2Results posted
- 4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe AsthmaCompletedNCT00818454Phase 2Results posted
- Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid TumoursCompletedNCT00809133Phase 1Results posted
- RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY TrialCompletedNCT00808067Phase 3Results posted
- Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCCompletedNCT00806819Phase 3Results posted
- LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerCompletedNCT00805194Phase 3Results posted
- Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid LeukaemiaCompletedNCT00804856Phase 2Results posted
- First Presentation of Parkinson Disease Patients to NeurologistCompletedNCT00802178Results posted
- Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveCompletedNCT00800683Phase 3Results posted
- Safety and Efficacy of Linagliptin (BI 1356) Plus Metformin in Type 2 Diabetes, Factorial DesignCompletedNCT00798161Phase 3Results posted
- Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease IICompletedNCT00796653Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic BladderCompletedNCT00796614Phase 2/3Results posted
- BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) PatientsCompletedNCT00796549Phase 2Results posted
- Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -ExperiencedCompletedNCT00793793Phase 1Results posted
- Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease ICompletedNCT00793624Phase 3Results posted
- 12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic PatientsCompletedNCT00789035Phase 2Results posted
- 12 / 48 wk Pivotal PFT vs PBO in COPD IICompletedNCT00782509Phase 3Results posted
- 12 / 48 Week Pivotal PFT vs PBO in COPD ICompletedNCT00782210Phase 3Results posted
- Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)CompletedNCT00776984Phase 3Results posted
- Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)CompletedNCT00774397Phase 2Results posted
- Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)CompletedNCT00772538Phase 3Results posted
- BI 10773 add-on to Metformin in Patients With Type 2 DiabetesCompletedNCT00749190Phase 2Results posted
- Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.TerminatedNCT00748709Phase 2Results posted
- A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is InappropriateCompletedNCT00740051Phase 3Results posted
- Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic FibrosisCompletedNCT00737100Phase 2Results posted
- PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.CompletedNCT00736502Results posted
- Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMCompletedNCT00736099Phase 3Results posted
- Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC PatientsCompletedNCT00730925Phase 2Results posted
- BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant GliomaCompletedNCT00727506Phase 2Results posted
- Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs SyndromeCompletedNCT00721279Results posted
- Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00720499Phase 2Results posted
- Study to Determine the Maximum Tolerated Dose of BIBW 2992 (Afatinib) When Combined With Cisplatin/Paclitaxel or Cisplatin/5-FU in Patients With Advanced Solid TumoursCompletedNCT00716417Phase 1Results posted
- The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic PatientsCompletedNCT00716092Phase 2Results posted
- A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120CompletedNCT00715403Phase 1Results posted
- LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or GefitinibCompletedNCT00711594Phase 2Results posted
- A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian CancerCompletedNCT00710762Phase 2Results posted
- Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic CancerCompletedNCT00710710Phase 2Results posted
- BIBW 2992 and Letrozole in Hormonoresistant Metastatic Breast CancerCompletedNCT00708214Phase 2Results posted
- A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate CancerCompletedNCT00706628Phase 2Results posted
- Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsCompletedNCT00699699Results posted
- Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)CompletedNCT00696020Phase 2Results posted
- Pramipexole ER vs. Placebo in FibromyalgiaTerminatedNCT00689052Phase 2Results posted
- Open-label Extension Study of Pramipexole in the Treatment of Children and Adolescents With Tourette SyndromeTerminatedNCT00681863Phase 3Results posted
- Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)CompletedNCT00680186Phase 3Results posted
- Tiotropium/Salmeterol Inhalation Powder in COPDTerminatedNCT00668772Phase 3Results posted
- Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPDCompletedNCT00662792Phase 3Results posted
- Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT00662740Phase 3Results posted
- Telmisartan+HCTZ (Hydrochlorothiazide), HypertensionCompletedNCT00659607Results posted
- J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term ObservationCompletedNCT00659581Results posted
- Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip ArthroplastyCompletedNCT00657150Phase 3Results posted
- BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)CompletedNCT00656136Phase 3Results posted
- Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)CompletedNCT00654498Phase 3Results posted
- Japanese P III vs Voglibose and PlaceboCompletedNCT00654381Phase 3Results posted
- Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole TreatmentCompletedNCT00651183Results posted
- Efficacy vs Placebo as Initial Combination Therapy With PioglitazoneCompletedNCT00641043Phase 3Results posted
- Special Survey Long-term Treatment With Tiotropium on COPDCompletedNCT00638183Results posted
- BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive TreatmentCompletedNCT00632749Phase 2Results posted
- Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual PracticeCompletedNCT00624377Results posted
- 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in HypertensionCompletedNCT00624052Phase 3Results posted
- STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial InfarctionCompletedNCT00623623Phase 3Results posted
- Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00622284Phase 3Results posted
- RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary SyndromeCompletedNCT00621855Phase 2Results posted
- Spiriva® 18µg Once Daily in Chinese COPD Patients of Different Disease SeveritiesCompletedNCT00621582Results posted
- Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic ControlCompletedNCT00621140Phase 3Results posted
- Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of LifeCompletedNCT00619177Results posted
- An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose CombinationCompletedNCT00618774Phase 3Results posted
- Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD GuidelinesCompletedNCT00615992Results posted
- Special Survey on Parkinson's Disease Patients Treated Long-term Use of PramipexoleCompletedNCT00615914Results posted
- Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & EfficacyCompletedNCT00615290Results posted
- Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in MulticentersCompletedNCT00615108Results posted
- Survey on PD Patients With Depressive SymptomsCompletedNCT00614575Results posted
- Open Label Study Telmisartan and Amlodipine in HypertensionCompletedNCT00614380Phase 3Results posted
- RUSSE / Russian Spiriva® Safety & Efficacy StudyCompletedNCT00613574Results posted
- Clinical EvaluatioN of TElmisartan-based Antihypertensive RegimenCompletedNCT00613314Results posted
- Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-DopaCompletedNCT00613301Results posted
- BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesCompletedNCT00602472Phase 3Results posted
- Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).CompletedNCT00601523Phase 3Results posted
- Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 DiabetesCompletedNCT00601250Phase 3Results posted
- Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PDCompletedNCT00577460Phase 3Results posted
- Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.CompletedNCT00563381Phase 4Results posted
- EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASACompletedNCT00562588Phase 4Results posted